Keywords: Celllectis, Lonza, Cell lines, Gene expression

Cellectis and Lonza achieve significant milestone on CHO-K1SV GS knock-out

Article | 21 July 2011

Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of French biotech firm Cellectis (Alternext: ALCLS), and Switzerland’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lonza

Cellectis

Go to company listing